GGrantIndex
Sort

172,184 grants matching inflammation

Mapping the Progression to HFpEF in the Elderly through Longitudinal Changes in Cardiac Function

$824,745
Hicham Skali · Brigham And Women'S Hospital · R01 · FY2021 · HL

The Development of RORgt Immunomodulators Targeting the TH17 Axis in IBD- Phase 2

$824,726
Gordon Alton · Visionary Pharmaceuticals, Inc. · R44 · FY2014 · DK

Effect of estrogen replacement on postmenopausal ART-associated comorbidity and viral latency

$824,709
Paul Kievit · Oregon Health & Science University · R01 · FY2021 · AG

Diffusion MRI Biomarkers of Peripheral Nerve Trauma

$824,668
Richard Dortch · St. Joseph'S Hospital And Medical Center · R61 · FY2023 · NS

MASLD protection by STAT5-regulated transcription factors

$824,655
Rhonda D. Kineman · University Of Illinois At Chicago · R01 · FY2025 · DK

Prospective Epidemiologic Study of Novel Etiologic Agents of Pelvic Inflammatory Disease

$824,632
Catherine L Haggerty · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AI

Technology Development Project - Increasing the complexity of ex vivo human airway models for studying immune response to viral infection

$824,595
Adam Williams · Jackson Laboratory · U19 · FY2025 · AI

Control of Cytokine Gene Expression in LymphoidMyeloid Cells

$824,556
Howard Young · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Study of Aging Latinas/os for Understanding Dementia in HIV (SALUD HIV)

$824,537
Monica G Rivera-Mindt · Fordham University · R01 · FY2023 · AG

Alcohol Metabolism, Functional Consequences and Apoptosis Signaling Mechanism

$824,518
Byoung-Joon Song · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2012 · AA

Project Heart: Biobehavioral effects on Cardiovascular Risk for Bereaved Spouses

$824,487
Christopher Paul Fagundes · Rice University · R01 · FY2017 · HL

Mechanisms of innate immune dysfunction in SIV/malaria co-infection in pregnancy

$824,479
Jennifer Manuzak · Tulane University Of Louisiana · R01 · FY2022 · HD

Systemic Racism and Biological Embodiment of Risk in Breast Cancer Mortality

$824,471
Tomi F Akinyemiju · Duke University · R01 · FY2022 · CA

Precursors of Stroke Incidence and Prognosis

$824,441
Philip A Wolf · Boston University Medical Campus · R01 · FY2010 · NS

Underdiagnosis of primary immunodeficiency disorders among racial and ethnic minorities: Recognize and Educate

$824,412
Mei-Sing Ong · Harvard Pilgrim Health Care, Inc. · R01 · FY2022 · MD

UAB Multidisciplinary Clinical Research Center

$824,361
S Louis Bridges · University Of Alabama At Birmingham · P60 · FY2015 · AR

Defining the role of IL-18 in atopic dermatitis

$824,258
Steven Van Dyken · Washington University · R01 · FY2023 · AI

Role of the innate immune defenses in viral infections

$824,239
Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK

Immunology of Acute and Chronic Viral Hepatitis

$824,239
Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK

Bridging pharmacodynamic biomarkers to clinical outcomes in pediatric inflammatory diseases

$824,198
John N Van Den Anker · Children'S Research Institute · P50 · FY2019 · HD

Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals

$824,145
Corinne Elizabeth Augelli-Szafran · Southern Research Institute · UG3 · FY2024 · AR

Combination gene editing protocol using CRISPR technology for HIV/AIDS cure in non-human primates

$824,124
Tricia Helen Burdo · Temple Univ Of The Commonwealth · R56 · FY2020 · AI

Alzheimer's Disease Hallmark Pathology and Associated Inflammation in the Retina

$824,043
Maya Koronyo-Hamaoui · Cedars-Sinai Medical Center · R01 · FY2024 · AG

Advanced multi-parametric 18F-FDG PET and MRI imaging parameters of response to immune suppressant therapy in patients with active cardiac sarcoidosis

$823,983
Zahi A. Fayad · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · HL

Vaccine Induced Immune-Inflammatory Response and Cardiovascular Risk

$823,874
Susan Cheng · Cedars-Sinai Medical Center · R01 · FY2021 · HL